Mirit I. Aladjem
Senior Investigator
Developmental Therapeutics Branch
National Cancer Institute
United States of America
Biography
Dr. Aladjem, head of DNA Replication group, received her Ph.D. from Tel Aviv University. She was a research associate at the Weizmann Institute of Science and then a postdoctoral fellow and a Leukemia Society Special Fellow at the Salk Institute in La Jolla, California. Dr. Aladjem joined the Laboratory of Molecular Pharmacology/Developmental Therapeutics Branch in October 1999 and was appointed a Senior Investigator in 2007. Dr. Aladjem's studies focus on cellular signaling pathways that modulate chromatin to regulate chromosome duplication and cell cycle progression.
Research Interest
1) cell cycle;. 2) chromatin; 3) signal transduction; 4) genomics 5) bioinformatics